ロード中...
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
BACKGROUND: Extracellular high mobility group box 1 protein (HMGB1) serves a central role in inflammation as a transporter protein, which binds other immune-activating molecules that are endocytosed via the receptor for advanced glycation end-products (RAGE). These pro-inflammatory complexes are ta...
保存先:
| 出版年: | Mol Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6460792/ https://ncbi.nlm.nih.gov/pubmed/30975096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10020-019-0081-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|